NCT04520412: A Study of Sodium Oligomannate (GV-971) in Participants With Mild to Moderate Alzheimer's Disease
- State
- Suspended
- Phase
- Phase 3
- People
- 2,046 planned
- Started
- 27 Oct 2020
- Primary completion
- Dec 2025
- Arms
- GV-971
- Results
- None posted
- 20 Aug 2020: Trial registered
- 27 Oct 2020: Trial started
- 23 Nov 2022: Trial suspended